A Phase-Ii Study of Combination of Pegylated Interferon Alfa-2a and Capecitabine in Locally Advanced or Metastatic Renal Cell Cancer
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-009-1134-2
Full Text
Open PDFAbstract
Available in full text
Date
September 22, 2009
Authors
Publisher
Springer Science and Business Media LLC